My NCBI | Sign In
RSS Settings
  • Search: Rothfield N F

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 107

    1.

    Development of a provisional core set of response measures for clinical trials of systemic sclerosis.

    Khanna D, Lovell DJ, Giannini E, Clements PJ, Merkel PA, Seibold JR, Matucci-Cerinic M, Denton CP, Mayes MD, Steen VD, Varga J, Furst DE; Scleroderma Clinical Trials Consortium co-authors.

    Ann Rheum Dis. 2008 May;67(5):703-9. Epub 2007 Sep 24.PMID: 17893248 [PubMed - indexed for MEDLINE]Related articles

    2.

    Outcome measurements in scleroderma: results from a delphi exercise.

    Gazi H, Pope JE, Clements P, Medsger TA, Martin RW, Merkel PA, Kahaleh B, Wollheim FA, Baron M, Csuka ME, Emery P, Belch JF, Hayat S, Lally EV, Korn JH, Czirjak L, Herrick A, Voskuyl AE, Bruehlmann P, Inanc M, Furst DE, Black C, Ellman MH, Moreland LW, Rothfield NF, Hsu V, Mayes M, McKown KM, Krieg T, Siebold JR.

    J Rheumatol. 2007 Mar;34(3):501-9. Epub 2007 Feb 1.PMID: 17299843 [PubMed - indexed for MEDLINE]Related articles

    3.

    Systemic lupus erythematosus evolving into rheumatoid arthritis.

    Rothfield NF, Lim AA.

    J Rheumatol. 2006 Jan;33(1):188-90.PMID: 16395767 [PubMed - indexed for MEDLINE]Related articles

    4.

    Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.

    Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, Sterz MG, Chung J, FitzGerald JD, Seibold JR, Varga J, Theodore A, Wigley FM, Silver RM, Steen VD, Mayes MD, Connolly MK, Fessler BJ, Rothfield NF, Mubarak K, Molitor J, Tashkin DP; Scleroderma Lung Study Group.

    Arthritis Rheum. 2005 Feb;52(2):592-600.PMID: 15692967 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.

    Petri MA, Mease PJ, Merrill JT, Lahita RG, Iannini MJ, Yocum DE, Ginzler EM, Katz RS, Gluck OS, Genovese MC, Van Vollenhoven R, Kalunian KC, Manzi S, Greenwald MW, Buyon JP, Olsen NJ, Schiff MH, Kavanaugh AF, Caldwell JR, Ramsey-Goldman R, St Clair EW, Goldman AL, Egan RM, Polisson RP, Moder KG, Rothfield NF, Spencer RT, Hobbs K, Fessler BJ, Calabrese LH, Moreland LW, Cohen SB, Quarles BJ, Strand V, Gurwith M, Schwartz KE.

    Arthritis Rheum. 2004 Sep;50(9):2858-68.PMID: 15452837 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Minocycline is not effective in systemic sclerosis: results of an open-label multicenter trial.

    Mayes MD, O'Donnell D, Rothfield NF, Csuka ME.

    Arthritis Rheum. 2004 Feb;50(2):553-7.PMID: 14872498 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories.

    Fritzler MJ, Wiik A, Tan EM, Smolen JS, McDougal JS, Chan EK, Gordon TP, Hardin JA, Kalden JR, Lahita RG, Maini RN, Reeves WH, Rothfield NF, Takasaki Y, Wilson M, Byrd MG, Slivka L, Koziol JA.

    J Rheumatol. 2003 Nov;30(11):2374-81.PMID: 14677180 [PubMed - indexed for MEDLINE]Related articles

    8.

    Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.

    Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsger TA Jr, Rothfield NF, Ellman MH, Collier DH, Weinstein A, Furst DE, Jiménez SA, White B, Seibold JR, Wigley FM; Scleroderma Clinical Trials Consortium.

    Arthritis Rheum. 2002 Sep;46(9):2410-20.PMID: 12355489 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content.

    Tan EM, Smolen JS, McDougal JS, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, Reeves WH, Rothfield NF, Takasaki Y, Wiik A, Wilson M, Koziol JA.

    J Rheumatol. 2002 Jan;29(1):68-74.PMID: 11824974 [PubMed - indexed for MEDLINE]Related articles

    10.

    A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity.

    Tan EM, Smolen JS, McDougal JS, Butcher BT, Conn D, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, Rothfield NF, Smeenk R, Takasaki Y, van Venrooij WJ, Wiik A, Wilson M, Koziol JA.

    Arthritis Rheum. 1999 Mar;42(3):455-64.PMID: 10088768 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.

    Wigley FM, Korn JH, Csuka ME, Medsger TA Jr, Rothfield NF, Ellman M, Martin R, Collier DH, Weinstein A, Furst DE, Jimenez SA, Mayes MD, Merkel PA, Gruber B, Kaufman L, Varga J, Bell P, Kern J, Marrott P, White B, Simms RW, Phillips AC, Seibold JR.

    Arthritis Rheum. 1998 Apr;41(4):670-7.PMID: 9550476 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Range of antinuclear antibodies in "healthy" individuals.

    Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, McDougal JS, Rothfield NF, Smeenk RJ, Takasaki Y, Wiik A, Wilson MR, Koziol JA.

    Arthritis Rheum. 1997 Sep;40(9):1601-11.PMID: 9324014 [PubMed - indexed for MEDLINE]Related articles

    13.

    A cross-reactive idiotype in scleroderma.

    Vázquez-Abad D, Tian L, Zanetti M, Rothfield NF.

    Clin Exp Immunol. 1997 Jun;108(3):420-7.PMID: 9182886 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    CRI-EM is a human idiotype highly specific for scleroderma.

    Vázquez-Abad D, Tian L, Monteón V, Zanetti M, Rothfield NF.

    Ann N Y Acad Sci. 1997 Apr 5;815:512-5. No abstract available. PMID: 9186713 [PubMed - indexed for MEDLINE]Related articles

    15.

    Racial aspects of comorbidity in systemic lupus erythematosus.

    Walsh SJ, Algert C, Rothfield NF.

    Arthritis Care Res. 1996 Dec;9(6):509-16.PMID: 9136295 [PubMed - indexed for MEDLINE]Related articles

    16.

    Chiasmal herniation as a complication of bromocriptine therapy.

    Taxel P, Waitzman DM, Harrington JF Jr, Fagan RH, Rothfield NF, Chen HH, Malchoff CD.

    J Neuroophthalmol. 1996 Dec;16(4):252-7.PMID: 8956160 [PubMed - indexed for MEDLINE]Related articles

    17.

    Antimalarial drugs in pregnancy--the North American experience.

    Parke AL, Rothfield NF.

    Lupus. 1996 Jun;5 Suppl 1:S67-9. Review.PMID: 8803915 [PubMed - indexed for MEDLINE]Related articles

    18.

    Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis.

    Vázquez-Abad D, Rothfield NF.

    Arthritis Rheum. 1996 Feb;39(2):292-6.PMID: 8849382 [PubMed - indexed for MEDLINE]Related articles

    19.

    Divergent racial trends in mortality from systemic lupus erythematosus.

    Walsh SJ, Algert C, Gregorio DI, Reisine ST, Rothfield NF.

    J Rheumatol. 1995 Sep;22(9):1663-8.PMID: 8523342 [PubMed - indexed for MEDLINE]Related articles

    20.

    Longitudinal study of anticentromere and antitopoisomerase-I isotypes.

    Vázquez-Abad D, Russell CA, Cusick SM, Earnshaw WC, Rothfield NF.

    Clin Immunol Immunopathol. 1995 Mar;74(3):257-70.PMID: 7859416 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    13 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity